ISPOR ATTENDING 2016 HTAi ANNUAL MEETING IN TOKYO THIS MAY

Published Apr 5, 2016
ANNOUNCEMENT Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will be attending the Health Technology Assessment international (HTAi) 2016 Annual Meeting in Tokyo, Japan on May 10-14, 2016. A number of ISPOR members will participate in the HTAi Meeting as speakers and attendees. ISPOR and HTAi often collaborate on scientific papers and other activities to advance the science and use of health technology assessment (HTA) worldwide. Registration for the HTAi Annual Meeting can be found here. For additional information, please contact Betsy Lane, director, chief marketing and communications officer at BLane@ispor.org or 609-586-4981 x112.

###

Related Stories

International Study Confirms Universally Applicable Framework for Defining Digital Health Interventions

Jan 21, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a comprehensive international study demonstrating that the PICOTS-ComTeC framework serves as an effective universal standard for defining patient-facing digital health interventions. The report, “Towards a Common Ground for Defining Digital Health Interventions, Mapping Digital Health Frameworks to PICOTS-ComTeC: An ISPOR Special Interest Group Report” was published in the January 2026 issue of Value in Health.

ISPOR Releases New 2026-2027 Top 10 HEOR Trends Report

Jan 20, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today the publication of its new “2026-2027 Top 10 HEOR Trends Report.” The Society publishes this report every two years as part of its horizon scanning and monitoring of the trends that affect healthcare decision making around the world.

ISPOR Announces New Executive Director for the ISPOR Institute for Healthcare Transformation

Jan 13, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Kelly Saldaña has been appointed as executive director for the ISPOR Institute for Healthcare Transformation.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×